These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 749332)

  • 1. Remarks on the pathogenic significance of HBsAg subtypes.
    Babeş VT; Constantinescu N; Dumitrescu D; Tatu A
    Virologie; 1978; 29(4):255-7. PubMed ID: 749332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The different biochemical course of HBsAg-negative and HBsAg-positive hepatitis (author's transl)].
    Strohm WD; Hossenfelder E; Stille W
    Z Gastroenterol; 1978 Jan; 16(1):13-23. PubMed ID: 74913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased transaminase activity in the patients and personnel of dialysis centers and problem of its assessment].
    Dschietzig W; Müller D
    Z Urol Nephrol; 1979 Aug; 72(8):589-94. PubMed ID: 506494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection.
    Stancek D; Blaskovicová H; Hajnická V; Husár K; Holenová Z; Mathernová V; Sudová J; Laktis K; Spanárová V
    Acta Virol; 1987 May; 31(3):234-42. PubMed ID: 2888287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
    Chung HT; Lai CL; Lok AS
    Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-year survey of viral hepatitis in West London.
    Stewart JS; Farrow LJ; Clifford RE; Lamb SG; Coghill NF; Lindon RL; Sanderson IM; Dodd PA; Smith HG; Preece JW; Zuckerman AJ
    Q J Med; 1978 Jul; 47(187):365-84. PubMed ID: 715174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal.
    Shrestha SM; Tsuda F; Okamoto H; Tokita H; Horikita M; Tanaka T; Miyakawa Y; Mayumi M
    Hepatology; 1994 Apr; 19(4):805-9. PubMed ID: 8138250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
    Paul S; Tabassum S; Islam MN
    Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of hepatitis B antigens in hepatic tissue in various forms of acute hepatitis].
    Sarno EN; Vieira LM; Alvariz FG
    Arq Gastroenterol; 1984; 21(2):68-74. PubMed ID: 6393924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids.
    Sandrini S; Callea F; Cristinelli L; Savoldi S; Setti G; Scaini P; Scolari F; Scalzini A; Pizzoccolo G; Maiorca R
    Nephrol Dial Transplant; 1990; 5(7):525-30. PubMed ID: 2130300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
    Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
    J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
    Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
    Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic validity of biochemical data and immunofluorescence microscopy in acute hepatitis B (author's transl)].
    Ohlen J; Neiss A; Drescher M; Selmair H; Richter J
    Acta Med Austriaca; 1981; 7(2):56-8. PubMed ID: 7010869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to persistence of Australia antigen.
    Sutnick AI; Bugbee SJ; London WT; Peyretti F; Litwin S; Blumberg BS
    Arch Intern Med; 1975 Aug; 135(8):1072-4. PubMed ID: 50767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis D infectivity profile among hepatitis B infected hospitalised patients in Calcutta.
    Bhattacharyya S; Dalal BS; Lahiri A
    Indian J Public Health; 1998; 42(4):108-12. PubMed ID: 10389522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta 2-microglobulin levels in chronic post-transfusion non A non B liver disease.
    Pirotte J; Borlée-Hermans G; Boniver J; Godon JP
    Biomed Pharmacother; 1988; 42(1):55-9. PubMed ID: 3136811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.